About Marker Therapeutics
Investors/Media
Analyst Coverage
Company Analyst
Cantor Fitzgerald
Kristen Kluska
Oppenheimer & Co Inc.
Matthew Biegler
Piper Sandler & Co.
Joseph Catanzaro, Ph.D.
Roth Capital Partners
Tony Butler, Ph.D
WBB Securities LLC
Steve Brozak, DMH

Marker Therapeutics, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Marker Therapeutics, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Marker Therapeutics, Inc. or its management. Marker Therapeutics, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.